Abstract: Described herein are systems, methods, storage media, and computer programs that support application development in a movable object environment, wherein protocol independent movable object application may be developed. In one embodiment, a request is received in a first protocol from an application executing on an affiliated device to access a movable object; the request in the first protocol is mapped to a function in an application programming interface (API), where the API is independent of the first protocol; and the movable object is directed to perform the function, via the API.

Abstract: A method for supporting application development in a movable object environment includes receiving a request to register one or more behavioral indicators for a movable object via a movable object controller, associating the one or more behavioral indicators with one or more indicator codes, and directing the movable object to behave based on an association between the one or more behavioral indicators and the one or more indicator codes.

Abstract: A method for providing location access management includes requesting access data from an access manager based on location data associated with a movable object, receiving the access data determining accessibility of one or more regions to the movable object, and sending the access data to the movable object via a connection to the movable object.

Abstract: A method for operating a vehicle includes, with aid of one or more processors, individually or collectively, receiving a parameter regarding operation of the vehicle, processing the parameter regarding the operation of the vehicle, and varying a restriction affecting operation of the vehicle based on the processing of the parameter.

Abstract: The invention features compounds of formula I or II: In one embodiment, the invention relates compounds and processes for conjugating ligand to oligonucleotide. The invention further relates to methods for treating various disorders and diseases such as viral infections, bacterial infections, parasitic infections, cancers, allergies, autoimmune diseases, immunodeficiencies and immunosuppression.

Abstract: The invention features compounds of formula I or II: In one embodiment, the invention relates compounds and processes for conjugating ligand to oligonucleotide. The invention further relates to methods for treating various disorders and diseases such as viral infections, bacterial infections, parasitic infections, cancers, allergies, autoimmune diseases, immunodeficiencies and immunosuppression.

Abstract: The invention features compounds of formula I or II: In one embodiment, the invention relates compounds and processes for conjugating ligand to oligonucleotide. The invention further relates to methods for treating various disorders and diseases such as viral infections, bacterial infections, parasitic infections, cancers, allergies, autoimmune diseases, immunodeficiencies and immunosuppression.

Abstract: The invention features compounds of formula I or II: In one embodiment, the invention relates compounds and processes for conjugating ligand to oligonucleotide. The invention further relates to methods for treating various disorders and diseases such as viral infections, bacterial infections, parasitic infections, cancers, allergies, autoimmune diseases, immunodeficiencies and immunosuppression.

Abstract: The invention relates to arabinose modified nucleoside 5? triphosphates and to the biosynthesis and amplification of oligonucleotides containing and/or from templates containing arabinose modified nucleosides. The invention further relates to methods of generating modified oligonucleotide libraries for use in selection strategies, such as SELEX. The arabinose modified oligonucleotides of the invention are useful for modulating target nucleic acid expression, such as RNA.

Abstract: Nucleic acid ligands (or aptamers) that form a G-tetrad containing at least one arabinose modified nucleotide are provided. Preferably, the arabinose modified nucleotide is 2?-deoxy-2?-fluoroarabinonucleotide (FANA) nucleotide. Methods of using aptamers the aptamers of the claimed invention are also provided.